ArticleScientific reports2026
Elevated body roundness index and epilepsy prevalence: a cross-sectional study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association Between a Body Shape Index and Epilepsy Among US Adults: Potential Indirect Pathway Through Depressive Symptoms.Brain and behavior · 2026Article
- Evaluation of metformin for epilepsy prevention or seizure control in people without evidence of diabetes: retrospective cohort study.Journal of neurology, neurosurgery, and psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Obesity and epilepsy have a complex bidirectional relationship. Body mass index is commonly used to study this association but does not capture fat distribution. The Body Roundness Index (BRI) reflects abdominal adiposity. To our knowledge, the association between BRI and epilepsy prevalence has not been reported. We analyzed 17,914 adults from NHANES 2013-March 2020. BRI was modeled continuously and by tertiles. We used logistic regression to estimate odds ratios (ORs) and 95% CIs for prevalent epilepsy. Restricted cubic spline analyses evaluated nonlinearity. Prespecified sensitivity analyses excluded participants taking valproate (n = 6) or carbamazepine (n = 23). Variance inflation factors assessed multicollinearity. No nonlinear relationship between BRI and epilepsy (P = 0.609). Higher BRI was associated with greater odds of prevalent epilepsy in fully adjusted models (per-unit OR, 1.08; 95% CI 1.01-1.15; P = 0.03). Compared with Q1, Q3 showed higher odds (OR, 1.73; 95% CI 1.06-2.89; P = 0.03), whereas Q2 did not reach significance (OR, 1.58; 95% CI 0.97-2.63; P = 0.07). Findings were materially unchanged after excluding valproate or carbamazepine users. Subgroup point estimates exceeded 1 across strata; tests for interaction were not significant. Higher BRI is associated with higher prevalence of epilepsy. These results underscore the potential importance of abdominal fat distribution in epilepsy and warrant confirmation in larger prospective studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.